Six companies have made the cut thus far to make presentations at the Council for Entrepreneurial development’s Venture 2003 conference.
The CED screening committee selected the six — five of which are biotech — from 28 applicants.
Those not selected in the first round will remain under consideration as CED moves through two more rounds of applications, a CED spokesperson said.
The next deadline for applications is Dec. 19.
The first six selected are:
Oriel Therapeutics, Inc.
The conference is set for April 22-23 in Chapel Hill.